Morgan Stanley Zivo Bioscience, Inc. Transaction History

Morgan Stanley

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	SELL	$2.48 - $19.98 $24 - $199	-10 Reduced 7.41%	125 $0
Q3 2022 Nov 14, 2022	BUY	$0.94 - $23.64 $9 - $236	10 Added 8.0%	135 $0
Q1 2022 May 13, 2022	SELL	$2.44 - $4.27 $2,303 - $4,030	-944 Reduced 88.31%	125 $0
Q4 2021 Feb 14, 2022	BUY	$2.73 - $4.48 $2,577 - $4,229	944 Added 755.2%	1,069 $3,000
Q3 2021 Nov 15, 2021	BUY	$2.8 - $5.45 $350 - $681	125 New	125 $1,000

Ticker ZIVO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 9,419,660
Market Cap $164M
Description
ZIVO Bioscience, Inc., a research and development company, engages in licensing and selling natural bioactive ingredients derived from its proprietary algae cultures to animal, human, and dietary supplement and medical food manufacturers. It operates in the biotech and agtech sectors, with an intellectual property portfolio comprising proprietar...

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

Stay updated on Morgan Stanley with notifications on news.